NSP vs. CCRN, KFY, RHI, ASGN, MAN, BBSI, HSII, KFRC, KELYA, and TBI
Should you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Korn/Ferry International (KFY), Robert Half (RHI), ASGN (ASGN), ManpowerGroup (MAN), Barrett Business Services (BBSI), Heidrick & Struggles International (HSII), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI).
Insperity vs. Its Competitors
Insperity (NYSE:NSP) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.
93.4% of Insperity shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 5.5% of Insperity shares are owned by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Insperity has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500.
Insperity has a net margin of 0.60% compared to Cross Country Healthcare's net margin of -0.70%. Insperity's return on equity of 35.32% beat Cross Country Healthcare's return on equity.
Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks.
Insperity presently has a consensus target price of $58.33, indicating a potential upside of 18.33%. Cross Country Healthcare has a consensus target price of $17.93, indicating a potential upside of 36.14%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Insperity.
In the previous week, Cross Country Healthcare had 1 more articles in the media than Insperity. MarketBeat recorded 1 mentions for Cross Country Healthcare and 0 mentions for Insperity. Insperity's average media sentiment score of 0.00 beat Cross Country Healthcare's score of -0.50 indicating that Insperity is being referred to more favorably in the media.
Summary
Insperity beats Cross Country Healthcare on 11 of the 16 factors compared between the two stocks.
Get Insperity News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Insperity Competitors List
Related Companies and Tools
This page (NYSE:NSP) was last updated on 10/6/2025 by MarketBeat.com Staff
